Cargando…

P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES

Detalles Bibliográficos
Autores principales: Martinez-Verbo, Laura, Villanueva, Lorea, Llinàs-Arias, Pere, Antonio García-Prieto, Carlos, Piñeyro, David, Oliver-Caldes, Aina, García-Ortiz, Almudena, Valeri, Antonio, De Larrea, Carlos Fernández, Martínez-López, Joaquin, Ferrer, Gerardo, Esteller, Manel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430445/
http://dx.doi.org/10.1097/01.HS9.0000970192.40461.5e
_version_ 1785090965804941312
author Martinez-Verbo, Laura
Villanueva, Lorea
Llinàs-Arias, Pere
Antonio García-Prieto, Carlos
Piñeyro, David
Oliver-Caldes, Aina
García-Ortiz, Almudena
Valeri, Antonio
De Larrea, Carlos Fernández
Martínez-López, Joaquin
Ferrer, Gerardo
Esteller, Manel
author_facet Martinez-Verbo, Laura
Villanueva, Lorea
Llinàs-Arias, Pere
Antonio García-Prieto, Carlos
Piñeyro, David
Oliver-Caldes, Aina
García-Ortiz, Almudena
Valeri, Antonio
De Larrea, Carlos Fernández
Martínez-López, Joaquin
Ferrer, Gerardo
Esteller, Manel
author_sort Martinez-Verbo, Laura
collection PubMed
description
format Online
Article
Text
id pubmed-10430445
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104304452023-08-17 P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES Martinez-Verbo, Laura Villanueva, Lorea Llinàs-Arias, Pere Antonio García-Prieto, Carlos Piñeyro, David Oliver-Caldes, Aina García-Ortiz, Almudena Valeri, Antonio De Larrea, Carlos Fernández Martínez-López, Joaquin Ferrer, Gerardo Esteller, Manel Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430445/ http://dx.doi.org/10.1097/01.HS9.0000970192.40461.5e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Martinez-Verbo, Laura
Villanueva, Lorea
Llinàs-Arias, Pere
Antonio García-Prieto, Carlos
Piñeyro, David
Oliver-Caldes, Aina
García-Ortiz, Almudena
Valeri, Antonio
De Larrea, Carlos Fernández
Martínez-López, Joaquin
Ferrer, Gerardo
Esteller, Manel
P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES
title P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES
title_full P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES
title_fullStr P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES
title_full_unstemmed P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES
title_short P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES
title_sort p822: epigenetic regulation of cd155 on multiple myeloma cells influences anti-tumor novel immunotherapeutic approaches
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430445/
http://dx.doi.org/10.1097/01.HS9.0000970192.40461.5e
work_keys_str_mv AT martinezverbolaura p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT villanuevalorea p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT llinasariaspere p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT antoniogarciaprietocarlos p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT pineyrodavid p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT olivercaldesaina p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT garciaortizalmudena p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT valeriantonio p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT delarreacarlosfernandez p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT martinezlopezjoaquin p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT ferrergerardo p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches
AT estellermanel p822epigeneticregulationofcd155onmultiplemyelomacellsinfluencesantitumornovelimmunotherapeuticapproaches